Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219.
Dahlén
S E
SE
Department of Physiology, Karolinska Institutet, Stockholm, Sweden.
Dahlén
B
B
Eliasson
E
E
Johansson
H
H
Björck
T
T
Kumlin
M
M
Boo
K
K
Whitney
J
J
Binks
S
S
King
B
B
D000328:Adult; D000485:Allergens / Q000494:pharmacology; D001249:Asthma / Q000209:etiology / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects*; D001985:Bronchial Provocation Tests; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications; D007211:Indoles; D020024:Leukotriene Antagonists; D017999:Leukotriene E4; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D013189:SRS-A / Q000031:analogs & derivatives / Q000652:urine; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000494:pharmacology*
D000485:Allergens; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013189:SRS-A; D013449:Sulfonamides; D014105:Tosyl Compounds; D017999:Leukotriene E4; C062735:zafirlukast